Improving the Antigenicity of sTn Antigen by Modification of Its Sialic Acid Residue for Development of Glycoconjugate Cancer Vaccines

Bioconjugate Chemistry - United States
doi 10.1021/bc060103s
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Improving the Antigenicity of sTn Antigen by Modification of Its Sialic Acid Residue for Development of Glycoconjugate Cancer Vaccines

English

Antimicrobial Glycoconjugate Vaccines: An Overview of Classic and Modern Approaches for Protein Modification

Chemical Society Reviews
Chemistry
2018English

Assessment of Sialic Acid Diversity in Cancer- And Non-Cancer Related CA125 Antigen Using Sialic Acid-Binding Ig-Like Lectins (Siglecs)

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2012English

Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines Against Invasive Nontyphoidal Salmonella Disease

PLoS ONE
Multidisciplinary
2015English

Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer

Frontiers in Immunology
AllergyImmunology
2014English

Antigenicity of Irradiated Pasteurella Tularensis Vaccines in Mice

1964English

Antigenicity of Methylated Deoxyribonucleic Acid

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1976English

Evaluation of Ion Mobility for the Separation of Glycoconjugate Isomers Due to Different Types of Sialic Acid Linkage, at the Intact Glycoprotein, Glycopeptide and Glycan Level

Journal of Proteomics
BiochemistryBiophysics
2018English

Development of Mutome-Specific Personalized Vaccines for Pancreatic Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy